Company: GIFLF
Filing Date: 2025-02-26
Form Type: 6-K
Source: 0001104659-25-017501
Chunk: 42

Company: Grifols SA
Filing Date: 2025-02-26
Form: 6-K
Chunk 42
---
 proceedings in which the Company or Group companies are involved are as follows:                             
 • CERUS CORPORATION vs. LABORATORIOS GRIFOLS, S.A.                                                                            
 Cerus Corporation ("Cerus") and Laboratorios Grifols, S.A. ("Grifols") entered into a Manufacturing and Supply                
 Agreement executed in 2016, pursuant to which Grifols was to manufacture and supply to Cerus processing and filters           
 sets to be used by Cerus in its own product (the "Agreement"). As a result of Grifols' decision to discontinue the            
 manufacturing, sale and support of its blood bag product business worldwide, Grifols was unable to comply with the            
 Agreement. In December 2021, Cerus filed a notice of arbitration in the UK pursuant to the terms of the Agreement             
 alleging wrongful termination of the Agreement by Grifols. Furthermore, in January 2022, Cerus filed injunctive               
 measures with the Courts of Rubí (Barcelona) requiring the suspension of the closure of Grifols' blood bags production        
 facility until the arbitration proceedings is finalized.                                                                      
 CURRENT PHASE: This January 2025, the parties have reached an agreement to put an end to the arbitration, by (a)              
 executing, on 16 January 2025, a settlement agreement that discontinues the arbitration in exchange for the payment by        
 Grifols to Cerus of the legal cost fixed at USD 1,091,731.31 and (b) executing, on 28 January 2025, a the deed of             
 variation of the existing manufacturing and supply agreement which sets forth that the agreement is to continue in            
 force and full effect until the new agreed-upon expiration date, namely, 30 October 2029. Consequently, all                   
 substantive issues have now been resolved, with only some minor procedural steps pending, such as, for example,               
 paying the Tribunal's costs of around £36,000 which shall be assumed by Grifols.                                              
 • EXECUTIVE COMMITTEE OF CNMV                                                                                                 
 On September 25, 2024, Grifols received notification that the Executive Committee of CNMV had initiated an                    
 administrative sanctioning procedure in connection with the conclusions reached by the CNMV on March 21, 2024.                
 These conclusions were disclosed by the Company as Inside Information on the same date and subsequently                       
 supplemented. The proposed sanction against Grifols for the incidents mentioned in the conclusions and                        
 supplementary